CENTENE CORP
CNCAPI behind this page
CNC Q1 2026 request
Playground key active
/api/financials?ticker=CNC&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 44,655 | 42,489 | +5.1% |
Show Product Lines breakouts |
|||
| Health Care Premium | 43,887 | 41,712 | +5.2% |
| Health Care Premium · All Other Segments | 433 | 530 | -18.3% |
| Health Care Premium · Commercial | 9,555 | 10,148 | -5.8% |
| Health Care Premium · Medicaid | 23,573 | 22,275 | +5.8% |
| Health Care Premium · Medicare | 10,326 | 8,759 | +17.9% |
| Premium and service revenues | 44,655 | 42,489 | +5.1% |
| Premium and service revenues · All Other Segments | 1,177 | 1,282 | -8.2% |
| Premium and service revenues · Commercial | 9,556 | 10,149 | -5.8% |
| Premium and service revenues · Medicaid | 23,596 | 22,299 | +5.8% |
| Premium and service revenues · Medicare | 10,326 | 8,759 | +17.9% |
| Service | 768 | 777 | -1.2% |
| Service · All Other Segments | 744 | 752 | -1.1% |
| Service · Commercial | 1 | 1 | 0.0% |
| Service · Medicaid | 23 | 24 | -4.2% |
| Premium Tax Revenue | 5,289 | 4,131 | +28.0% |
Show Business Segments breakouts |
|||
| Medicaid · Operating Segments | 5,289 | 4,131 | +28.0% |
| Revenue | 49,944 | 46,620 | +7.1% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,177 | 1,282 | -8.2% |
| All Other Segments · Intersegment Elimination | -4,146 | -4,164 | +0.4% |
| All Other Segments · Operating Segments | 4,146 | 4,164 | -0.4% |
| Commercial | 9,556 | 10,149 | -5.8% |
| Medicaid | 28,885 | 26,430 | +9.3% |
| Medicare | 10,326 | 8,759 | +17.9% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -4,146 | -4,164 | +0.4% |
| Operating Segments | 4,146 | 4,164 | -0.4% |
| Policyholder Benefits And Claims Incurred Net | 38,303 | 36,503 | +4.9% |
Show Business Segments breakouts |
|||
| All Other Segments | 378 | 498 | -24.1% |
| Commercial | 7,198 | 7,607 | -5.4% |
| Medicaid | 21,955 | 20,843 | +5.3% |
| Medicare | 8,772 | 7,555 | +16.1% |
| Cost of Revenue | 702 | 698 | +0.6% |
Show Business Segments breakouts |
|||
| All Other Segments | 679 | 674 | +0.7% |
| Medicaid | 23 | 24 | -4.2% |
| Selling, General & Administrative | 3,397 | 3,353 | +1.3% |
| Depreciation | 134 | 142 | -5.6% |
| Amortization Of Intangible Assets | 166 | 173 | -4.0% |
| Premium Tax Expense | 5,381 | 4,217 | +27.6% |
| Total Costs & Expenses | 48,083 | 45,086 | +6.6% |
| Operating Income | 1,861 | 1,534 | +21.3% |
| Investment Income Nonoperating | 407 | 382 | +6.5% |
| Gain Loss On Extinguishment Of Debt Including Cash Portion | -5 | — | — |
| Interest Expense | -164 | -170 | +3.5% |
| Income Before Taxes | 2,099 | 1,746 | +20.2% |
| Income Tax Expense (Benefit) | 560 | 432 | +29.6% |
| Net Income | 1,539 | 1,314 | +17.1% |
| Net Income Loss Attributable To Noncontrolling Interest | 2 | -3 | +166.7% |
| Net Income | 1,541 | 1,311 | +17.5% |
| EPS (Basic) | 3.13 | 2.64 | +18.6% |
| EPS (Diluted) | 3.11 | 2.63 | +18.3% |
| Wtd Avg Shares (Basic) | 492,069 | 496,214 | -0.8% |
| Wtd Avg Shares (Diluted) | 495,591 | 498,180 | -0.5% |
| Gross Profit | 5,650 | 5,288 | +6.8% |
Show Business Segments breakouts |
|||
| All Other Segments | 120 | 110 | +9.1% |
| Commercial | 2,358 | 2,542 | -7.2% |
| Medicaid | 1,618 | 1,432 | +13.0% |
| Medicare | 1,554 | 1,204 | +29.1% |
| Other Non-Operating Income (Expense) | 238 | 212 | +12.3% |
| Comprehensive Income | 1,428 | 1,478 | -3.4% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 38,303 | 36,325 | +5.4% |
Show Business Segments breakouts |
|||
| All Other Segments | 378 | 498 | -24.1% |
| Commercial | 7,198 | 7,607 | -5.4% |
| Medicaid | 21,955 | 20,843 | +5.3% |
| Medicare | 8,772 | 7,377 | +18.9% |
| Revenue From Contract With Customer Including Assessed Tax | 49,944 | 46,620 | +7.1% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 1,177 | 1,282 | -8.2% |
| Commercial · Operating Segments | 9,556 | 10,149 | -5.8% |
| Medicaid · Operating Segments | 28,885 | 26,430 | +9.3% |
| Medicare · Operating Segments | 10,326 | 8,759 | +17.9% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 21,264 | 14,815 | +43.5% |
| Premiums And Other Receivables Net | 19,426 | 22,436 | -13.4% |
| Short-Term Investments | 2,477 | 2,472 | +0.2% |
| Other Assets Current | 1,822 | 1,565 | +16.4% |
| Total Current Assets | 44,989 | 41,288 | +9.0% |
| Non-Current Assets | |||
| Long Term Investments | 16,599 | 18,268 | -9.1% |
| Other Restricted Assets Noncurrent | 1,432 | 1,409 | +1.6% |
| Property, Plant & Equipment | 2,090 | 2,044 | +2.3% |
| Goodwill | 10,835 | 17,558 | -38.3% |
| Other Non-Current Assets | 866 | 1,241 | -30.2% |
| Total Assets | 81,175 | 87,044 | -6.7% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 4,364 | 5,236 | -16.7% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 20,627 | 19,911 | +3.6% |
Show Business Segments breakouts |
|||
| All Other Segments | 29 | 177 | -83.6% |
| Commercial | 5,116 | 4,690 | +9.1% |
| Medicaid | 11,416 | 11,297 | +1.1% |
| Medicare | 4,066 | 3,747 | +8.5% |
| Accounts Payable And Accrued Liabilities Current | 16,832 | 13,948 | +20.7% |
| Returnof Premium Payable | 1,570 | 2,403 | -34.7% |
| Deferred Revenue (Current) | 953 | 869 | +9.7% |
| Current Portion of Long-Term Debt | 63 | 12 | +425.0% |
| Total Current Liabilities | 40,045 | 37,143 | +7.8% |
| Non-Current Liabilities | |||
| Long-Term Debt | 16,308 | 18,308 | -10.9% |
| Deferred Tax Liabilities | 744 | 708 | +5.1% |
| Other Non-Current Liabilities | 2,551 | 2,866 | -11.0% |
| Total Liabilities | 59,648 | 59,025 | +1.1% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 25 | 12 | +108.3% |
| Stockholders' Equity | |||
| Common Stock | 1 | 1 | 0.0% |
| Additional Paid In Capital Common Stock | 20,823 | 20,631 | +0.9% |
| Accumulated Other Comprehensive Income | -171 | -337 | +49.3% |
| Retained Earnings | 10,215 | 16,659 | -38.7% |
| Treasury Stock Common Value | -9,441 | -9,038 | -4.5% |
| Total Stockholders' Equity | 21,427 | 27,916 | -23.2% |
| Minority Interest | 75 | 91 | -17.6% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 21,502 | 28,007 | -23.2% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -171 | -337 | +49.3% |
| Additional Paid In Capital | 20,823 | 20,631 | +0.9% |
| Common Stock | 1 | 1 | 0.0% |
| Noncontrolling Interest | 75 | 91 | -17.6% |
| Retained Earnings | 10,215 | 16,659 | -38.7% |
| Treasury Stock Common | -9,441 | -9,038 | -4.5% |
| Total Liabilities & Equity | 81,175 | 87,044 | -6.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation And Amortization | 300 | 314 | -4.5% |
| Stock-Based Compensation | 67 | 59 | +13.6% |
| Gains Losses On Extinguishment Of Debt | 5 | — | — |
| Deferred Income Taxes | -53 | -27 | -96.3% |
| Increase Decrease In Premiums Receivable | -1,353 | -2,684 | +49.6% |
| Increase Decrease In Other Operating Assets | -188 | -669 | +71.9% |
| Increase Decrease In Health Care Insurance Liabilities | 95 | 1,603 | -94.1% |
| Change in Deferred Revenue | 217 | 208 | +4.3% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 2,905 | 563 | +416.0% |
| Change in Other Liabilities | 849 | 814 | +4.3% |
| Other Operating Activities Cash Flow Statement | -17 | 5 | -440.0% |
| Net Cash from Operations | 4,366 | 1,510 | +189.1% |
| Investing Activities | |||
| Capital Expenditures | -200 | -135 | -48.1% |
| Payments To Acquire Investments | -987 | -1,630 | +39.4% |
| Proceeds From Sale Maturity And Collections Of Investments | 1,276 | 1,236 | +3.2% |
| Net Cash from Investing | 89 | -529 | +116.8% |
| Financing Activities | |||
| Repayments Of Long Term Debt | -1,046 | -958 | -9.2% |
| Share Repurchases | -29 | -41 | +29.3% |
| Proceeds From Issuance Of Common Stock | 10 | 10 | 0.0% |
| Proceeds From Payments For Other Financing Activities | 2 | -11 | +118.2% |
| Net Cash from Financing | -1,063 | -250 | -325.2% |
| Supplemental | |||
| Interest Paid | 146 | 129 | +13.2% |
| Income Taxes Paid | -19 | 7 | -371.4% |
| Other Cash Flow | |||
| Net Change in Cash | 3,392 | 731 | +364.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations | 4 | — | — |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 21,353 | 14,887 | +43.4% |
| Restricted Cash And Cash Equivalents | 89 | 72 | +23.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.